Samsung Biologics

Glycosylation is a common and critical post-translational modification that affects protein function and therapeutic efficacy, making its monitoring and accurate quantification essential for drug development.

The identification, characterization, and quantitation of host cell protein (HCP) impurities are a critical challenge in the biopharmaceutical industry. Advanced LC-MS techniques can be integrated into manufacturing workflows to mitigate risks and ensure higher product quality and improved patient safety.

Explore how Samsung Biologics’ DEVELOPICK™ can help mitigate development risk and identify candidates with the best potential for advancement to IND and beyond

Webinar Date/Time: Wednesday May 31, 2023 at 11am EDT | 10am CDT | 8am PDT

Webinar Date/Time: Thursday, December 8, 2022 at 11am EST | 10am CST | 8 am PST

Samsung Biologics is responding to industry challenges with various development projects and services that improve overall timelines and efficiencies when manufacturing new medicines.

All drugs approved in the US marketplace went through an extensive, multi- million dollars, multi-year journey before being available to patients. In order to bring a new drug to the market place requires extensive resources, technical acumen, and an unbendable commitment to the goal. CDMOs are alongside pharma companies helping them navigate the process and mitigate risk. By choosing the right partnerships, you can give your drug production the competitive advantage it brings to the marketplace. Listen to Soojin Han, Director of the CLD group at Samsung Biologics, as she talks about what is the CDMO partnership and how Samsung Biologics can help many scientists for drug development to speed up the drug product to the marketplace and support many people's health life.

Tuesday August 31, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CESTEfficiency for validation, changes to traditional practices to be more efficient and effective .

This application note describes key activities to accelerate biopharmaceutical tech transfer to support faster development and manufacturing programs.

• How alternating tangential filtration differs from other perfusion methods • The benefits of alternating tangential filtration

/